{
    "organizations": [],
    "uuid": "4b93075c49f34adbec0197c52bf3f4d592fc5ed9",
    "author": "",
    "url": "https://www.reuters.com/article/esperion-thera-study/esperions-cholesterol-drug-succeeds-in-mid-stage-study-idUSL3N1R94GB",
    "ord_in_thread": 0,
    "title": "Esperion's cholesterol drug succeeds in mid-stage study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27, 2018 / 11:53 AM / Updated 10 minutes ago Esperion's cholesterol drug succeeds in mid-stage study Reuters Staff 1 Min Read March 27 (Reuters) - Esperion Therapeutics Inc said on Tuesday a mid-stage study of its experimental oral drug met the main goal of reducing cholesterol. Esperionâ€™s 8-week study tested a 180 mg per day dose of its drug, bempedoic acid, versus a placebo in 58 patients with high cholesterol. Shares of the company were up 2.17 percent at $73.35 in premarket trading. (Reporting by Akankshita Mukhopadhyay in Bengaluru)",
    "published": "2018-03-27T14:51:00.000+03:00",
    "crawled": "2018-03-27T15:13:47.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "esperion",
        "cholesterol",
        "drug",
        "succeeds",
        "study",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "esperion",
        "therapeutic",
        "inc",
        "said",
        "tuesday",
        "study",
        "experimental",
        "oral",
        "drug",
        "met",
        "main",
        "goal",
        "reducing",
        "cholesterol",
        "esperion",
        "study",
        "tested",
        "mg",
        "per",
        "day",
        "dose",
        "drug",
        "bempedoic",
        "acid",
        "versus",
        "placebo",
        "patient",
        "high",
        "cholesterol",
        "share",
        "company",
        "percent",
        "premarket",
        "trading",
        "reporting",
        "akankshita",
        "mukhopadhyay",
        "bengaluru"
    ]
}